Behavioral Neuroscience – News and Features

A new study of nearly 10,000 adolescents has identified distinct differences in the brain structures of those who used substances before age 15.

A groundbreaking discovery has highlighted lithium—a drug long used to treat bipolar disorder and depression—as a potential therapy for autism spectrum disorder.

Researchers have identified hundreds of novel genetic variants associated with autism across an ancestrally diverse cohort.

A new study of mostly Latino people found that those with lower oxygen levels during sleep had changes in the deep parts of the brain, the white matter, a common finding of decreased brain health that develops with age.

A chemogenetic tool could form the basis of a gene therapy for chronic pain by turning off pain receptors.

This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.

A phase 1/2 trial indicates that a new drug can address the cognitive difficulties associated with Down syndrome.

Caltech researchers found that humans think at 10 bits per second, far slower than the billion bits per second gathered by sensory systems. This limitation, rooted in evolutionary navigation systems, explains why we process one thought at a time.

A new study published in BMJ investigated whether occupations that engage specific brain regions more intensively could reduce the burden of AD.

Researchers found that accelerated biological aging, measured via DNA methylation, predicts frailty, cognitive decline, and dementia risk. Females experience memory loss, while males show slowed mental processing and nearly double the dementia risk.